Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 64 results.
User Information
Export Records
  1. 1.   Pathogenic germline IKZF1 variant alters hematopoietic gene expression profiles
  2. Brodie,Seth; Khincha, Payal P.; Giri, Neelam; Bouk,Aaron; Steinberg,Mia; Dai,Jieqiong; Jessop, Lea; Donovan, Frank X.; Chandrasekharappa, Settara C.; de Andrade, Kelvin C.; Maric, Irina; Ellis, Steven R.; Mirabello, Lisa; Alter, Blanche P.; Savage, Sharon A.
  3. COLD SPRING HARBOR MOLECULAR CASE STUDIES. 2021, AUG; 7(4):
  1. 2.   Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent Elicitation
  2. Cheung, Crystal Sao-Fong; Fruehwirth, Alexander; Paparoditis, Philipp Carl Georg; Shen, Chen-Hsiang; Foglierini, Mathilde; Joyce, M Gordon; Leung, Kwanyee; Piccoli, Luca; Rawi, Reda; Silacci-Fregni, Chiara; Tsybovsky,Yaroslav; Verardi, Raffaello; Wang, Lingshu; Wang, Shuishu; Yang, Eun Sung; Zhang, Baoshan; Zhang, Yi; Chuang, Gwo-Yu; Corti, Davide; Mascola, John R; Shapiro, Lawrence; Kwong, Peter D; Lanzavecchia, Antonio; Zhou, Tongqing
  3. Cell reports. 2020, Sep 01; 32(9): 108088.
  1. 3.   IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
  2. Richardson, Simone I; Lambson, Bronwen E; Crowley, Andrew R; Bashirova,Arman; Scheepers, Cathrine; Garrett, Nigel; Abdool Karim, Salim; Mkhize, Nonhlanhla N; Carrington,Mary; Ackerman, Margaret E; Moore, Penny L; Morris, Lynn
  3. PLoS pathogens. 2019, Dec 16; 15(12): e1008064.
  1. 4.   CD19-positive antibody-secreting cells provide immune memory
  2. Groves, C. J.; Carrell, Jeff; Grady, R.; Rajan, B.; Morehouse, C. A.; Halpin, R.; Wang, J.; Wu, J.; Shrestha, Y.; Rayanki, R.; Kolbeck, R.; Wang, Y.; Herbst, R.
  3. Blood advances. 2018, NOV 27; 2(22): 3163-3176.
  1. 5.   CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease
  2. De Ravin, Suk See; Li, Linhong; Wu, Xiaolin; Choi, Uimook; Allen, Cornell; Koontz, Sherry; Lee, Janet; Theobald-Whiting, Narda; Chu, Jessica; Garofalo, Mary; Sweeney, Colin; Kardava, Lela; Moir, Susan; Viley, Angelia; Natarajan, Pachai; Su, Ling; Kuhns, Douglas; Zarember, Kol A.; Peshwa, Madhusudan V.; Malech, Harry L.
  3. SCIENCE TRANSLATIONAL MEDICINE. 2017, Jan 11; 9(372): eaah3480.
  1. 6.   Role of O-Glycosylation and Expression of CD43 and CD45 on the Surfaces of Effector T Cells in Human T Cell Leukemia Virus Type 1 Cell-to-Cell Infection
  2. Mazurov, D.; Ilinskaya, A.; Heidecker, G.; Filatov, A.
  3. Journal of Virology. 2012, Mar; 86(5): 2447-2458.
  1. 7.   Trafficking of a Dual-Modality Magnetic Resonance and Fluorescence Imaging Superparamagnetic Iron Oxide-Based Nanoprobe to Lymph Nodes
  2. Bumb, A.; Regino, C. A. S.; Egen, J. G.; Bernardo, M.; Dobson, P. J.; Germain, R. N.; Choyke, P. L.; Brechbiel, M. W.
  3. Molecular Imaging and Biology. 2011, Dec; 13(6): 1163-1172.
  1. 8.   Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer
  2. Cherkasova, E.; Malinzak, E.; Rao, S.; Takahashi, Y.; Senchenko, V. N.; Kudryavtseva, A. V.; Nickerson, M. L.; Merino, M.; Hong, J. A.; Schrump, D. S.; Srinivasan, R.; Linehan, W. M.; Tian, X.; Lerman, M. I.; Childs, R. W.
  3. Oncogene. 2011, Nov; 30(47): 4697-4706.
  1. 9.   High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy
  2. Uldrick, T. S.; Polizzotto, M. N.; Aleman, K.; O'Mahony, D.; Wyvill, K. M.; Wang, V.; Marshall, V.; Pittaluga, S.; Steinberg, S. M.; Tosato, G.; Whitby, D.; Little, R. F.; Yarchoan, R.
  3. Blood. 2011, Jun; 117(26): 6977-6986.
  1. 10.   Toll-Like Receptor 9 Is Required for Opioid-Induced Microglia Apoptosis
  2. He, L.; Li, H.; Chen, L.; Miao, J. Y.; Jiang, Y. L.; Zhang, Y.; Xiao, Z. X.; Hanley, G.; Li, Y.; Zhang, X. M.; LeSage, G.; Peng, Y.; Yin, D. L.
  3. Plos One. 2011, Apr; 6(4): 10.
  1. 11.   LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?
  2. Orr, S. J.; McVicar, D. W.
  3. Journal of Leukocyte Biology. 2011, Jan; 89(1): 11-19.
  1. 12.   Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production
  2. Zhang, S. L.; Readinger, J. A.; DuBois, W.; Janka-Junttila, M.; Robinson, R.; Pruitt, M.; Bliskovsky, V.; Wu, J. Z.; Sakakibara, K.; Patel, J.; Parent, C. A.; Tessarollo, L.; Schwartzberg, P. L.; Mock, B. A.
  3. Blood. 2011, Jan; 117(4): 1228-1238.
  1. 13.   Clinical Manifestations, Etiology, and Pathogenesis of the Hyper-IgE Syndromes
  2. Freeman, A. F.; Holland, S. M.
  3. Pediatric Research. 2009 65(5): 32R-37R.
  1. 15.   Ly49 C/I-dependent NKT cell-derived IL-10 is required for corneal graft survival and peripheral tolerance
  2. Watte, C. M.; Nakamura, T.; Lau, C. H.; Ortaldo, J. R.; Stein-Streilein, J.
  3. Journal of Leukocyte Biology. 2008 83(4): 928-935.
  1. 16.   Regulation of thymic NKT cell development by the B7-CD28 costimulatory pathway
  2. Williams, J. A.; Lumsden, J. M.; Yu, X.; Feigenbamn, L.; Zhang, J. J.; Steinberg, S. M.; Hodes, R. J.
  3. Journal of Immunology. 2008 181(2): 907-917.
  1. 17.   Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation
  2. Deane, J. A.; Pisitkun, P.; Barrett, R. S.; Feigenbaum, L.; Town, T.; Ward, J. M.; Flavell, R. A.; Boll, S.
  3. Immunity. 2007, Nov; 27(5): 801-810.
  1. 18.   Splenic CD19(-)CD35(+)B220(+) cells function as an inducer of follicular dendritic cell network formation
  2. Murakami, T.; Chen, X.; Hase, K.; Sakamoto, A.; Nishigaki, C.; Ohno, H.
  3. Blood. 2007, Aug; 110(4): 1215-1224.
  1. 19.   NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye
  2. Sonoda, K. H.; Nakamura, T.; Young, H. A.; Hart, D.; Carmeliet, P.; Stein-Streilein, J.
  3. Journal of Immunology. 2007, Aug; 179(4): 2215-2222.
  1. 20.   Regulation of AID expression in the immune response
  2. Crouch, E. E.; Li, Z. Y.; Takizawa, M.; Fichtner-Feigl, S.; Gourzi, P.; Montano, C.; Feigenbaum, L.; Wilson, P.; Janz, S.; Papavasiliou, F. N.; Casellas, R.
  3. Journal of Experimental Medicine. 2007, May; 204(5): 1145-1156.
  1. 21.   Low doses of antigen coupled to anti-CR2 mAbs induce rapid and enduring IgG immune responses in mice and in cynomolgus monkeys
  2. Whipple, E. C.; Ditto, A. H.; Shanahan, R. S.; Gatesman, J. J.; Little, S. F.; Taylor, R. P.; Lindorfer, M. A.
  3. Molecular Immunology. 2007, Jan; 44(4): 377-388.
  1. 22.   Local and systemic effects of intranodally injected CpG-C immunostimulatory-oligodeoxyribonucleotides in macaques
  2. Teleshova, N.; Kenney, J.; Van Nest, G.; Marshall, J.; Lifson, J. D.; Sivin, I.; Dufour, J.; Bohm, R.; Gettie, A.; Robbiani, M.
  3. Journal of Immunology. 2006, Dec; 177(12): 8531-8541.
  1. 23.   Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model
  2. He, H.; Wisner, P.; Yang, G. J.; Hu, H. M.; Haley, D.; Miller, W.; O'Hara, A.; Alvord, W. G.; Clegg, C. H.; Fox, B. A.; Urba, W. J.; Walker, E. B.
  3. Journal of Translational Medicine. 2006, Jun; 4
  1. 24.   Host immunogenetics and control of human herpesvirus-8 infection
  2. Brown, E. E.; Fallin, M. D.; Goedert, J. J.; Hutchinson, A.; Vitale, F.; Lauria, C.; Giuliani, M.; Marshall, V.; Mbisa, G.; Serraino, D.; Messina, A.; Durum, S.; Whitby, D.; Chanock, S. J.; Kaposi Sarcoma Genetics Working Group
  3. Journal of Infectious Diseases. 2006, Apr; 193(8): 1054-1062.
  1. 25.   HTLV-1 Gag protein associates with CD82 tetraspanin microdomains at the plasma membrane
  2. Mazurov, D.; Heidecker, G.; Derse, D.
  3. Virology. 2006, MAR 1; 346(1): 194-204.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel